Cargando…

Evaluation of Study Engagement With an mHealth Intervention (THR1VE) to Treat Diabetes Distress in Teens With Type 1 Diabetes: Randomized Clinical Trial

BACKGROUND: Positive psychology interventions demonstrate improvements in diabetes self-management and quality of life among adults with chronic health conditions, but few interventions for adolescents use this approach. OBJECTIVE: This study describes engagement with a positive psychology intervent...

Descripción completa

Detalles Bibliográficos
Autores principales: LeStourgeon, Lauren, Bergner, Erin, Datye, Karishma, Streisand, Randi, Jaser, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594399/
https://www.ncbi.nlm.nih.gov/pubmed/37800881
http://dx.doi.org/10.2196/47089
_version_ 1785124641216397312
author LeStourgeon, Lauren
Bergner, Erin
Datye, Karishma
Streisand, Randi
Jaser, Sarah
author_facet LeStourgeon, Lauren
Bergner, Erin
Datye, Karishma
Streisand, Randi
Jaser, Sarah
author_sort LeStourgeon, Lauren
collection PubMed
description BACKGROUND: Positive psychology interventions demonstrate improvements in diabetes self-management and quality of life among adults with chronic health conditions, but few interventions for adolescents use this approach. OBJECTIVE: This study describes engagement with a positive psychology intervention delivered via automated SMS text messages aimed at treating diabetes distress and improving diabetes outcomes. In addition, demographic and clinical predictors of intervention engagement were examined. METHODS: Adolescents with type 1 diabetes (ages 13-17 years) who reported at least moderate diabetes distress were randomized to receive either the education or positive affect + education intervention, comprising 8 weeks of automated SMS text messages. Engagement was assessed as the response to the SMS text messages. Adolescents completed satisfaction surveys 3 months post intervention, and a subset of participants from both intervention groups completed exit interviews. RESULTS: Adolescents in both groups reported high levels of satisfaction with the study, with 95% (163/172) reporting that they would participate again. Engagement with the SMS text messages was high; on average, adolescents in the positive affect + education group responded to 92.5% of intervention messages, and their caregivers responded to 88.5% of messages. There were no significant differences in rates of engagement related to adolescents’ sex, age, device use, or race/ethnicity. CONCLUSIONS: A positive psychology intervention for adolescents delivered via automated SMS text messages was feasible and acceptable across genders, ages, and racial/ethnic groups, suggesting potential for wider dissemination. TRIAL REGISTRATION: ClinicalTrials.gov NCT03845465; https://clinicaltrials.gov/study/NCT03845465
format Online
Article
Text
id pubmed-10594399
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher JMIR Publications Inc
record_format MEDLINE/PubMed
spelling pubmed-105943992023-10-25 Evaluation of Study Engagement With an mHealth Intervention (THR1VE) to Treat Diabetes Distress in Teens With Type 1 Diabetes: Randomized Clinical Trial LeStourgeon, Lauren Bergner, Erin Datye, Karishma Streisand, Randi Jaser, Sarah JMIR Pediatr Parent Original Paper BACKGROUND: Positive psychology interventions demonstrate improvements in diabetes self-management and quality of life among adults with chronic health conditions, but few interventions for adolescents use this approach. OBJECTIVE: This study describes engagement with a positive psychology intervention delivered via automated SMS text messages aimed at treating diabetes distress and improving diabetes outcomes. In addition, demographic and clinical predictors of intervention engagement were examined. METHODS: Adolescents with type 1 diabetes (ages 13-17 years) who reported at least moderate diabetes distress were randomized to receive either the education or positive affect + education intervention, comprising 8 weeks of automated SMS text messages. Engagement was assessed as the response to the SMS text messages. Adolescents completed satisfaction surveys 3 months post intervention, and a subset of participants from both intervention groups completed exit interviews. RESULTS: Adolescents in both groups reported high levels of satisfaction with the study, with 95% (163/172) reporting that they would participate again. Engagement with the SMS text messages was high; on average, adolescents in the positive affect + education group responded to 92.5% of intervention messages, and their caregivers responded to 88.5% of messages. There were no significant differences in rates of engagement related to adolescents’ sex, age, device use, or race/ethnicity. CONCLUSIONS: A positive psychology intervention for adolescents delivered via automated SMS text messages was feasible and acceptable across genders, ages, and racial/ethnic groups, suggesting potential for wider dissemination. TRIAL REGISTRATION: ClinicalTrials.gov NCT03845465; https://clinicaltrials.gov/study/NCT03845465 JMIR Publications Inc 2023-10-05 /pmc/articles/PMC10594399/ /pubmed/37800881 http://dx.doi.org/10.2196/47089 Text en © Lauren LeStourgeon, Erin Bergner, Karishma Datye, Randi Streisand, Sarah Jaser. Originally published in JMIR Pediatrics and Parenting (https://pediatrics.jmir.org), 5.10.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Pediatrics and Parenting, is properly cited. The complete bibliographic information, a link to the original publication on https://pediatrics.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
LeStourgeon, Lauren
Bergner, Erin
Datye, Karishma
Streisand, Randi
Jaser, Sarah
Evaluation of Study Engagement With an mHealth Intervention (THR1VE) to Treat Diabetes Distress in Teens With Type 1 Diabetes: Randomized Clinical Trial
title Evaluation of Study Engagement With an mHealth Intervention (THR1VE) to Treat Diabetes Distress in Teens With Type 1 Diabetes: Randomized Clinical Trial
title_full Evaluation of Study Engagement With an mHealth Intervention (THR1VE) to Treat Diabetes Distress in Teens With Type 1 Diabetes: Randomized Clinical Trial
title_fullStr Evaluation of Study Engagement With an mHealth Intervention (THR1VE) to Treat Diabetes Distress in Teens With Type 1 Diabetes: Randomized Clinical Trial
title_full_unstemmed Evaluation of Study Engagement With an mHealth Intervention (THR1VE) to Treat Diabetes Distress in Teens With Type 1 Diabetes: Randomized Clinical Trial
title_short Evaluation of Study Engagement With an mHealth Intervention (THR1VE) to Treat Diabetes Distress in Teens With Type 1 Diabetes: Randomized Clinical Trial
title_sort evaluation of study engagement with an mhealth intervention (thr1ve) to treat diabetes distress in teens with type 1 diabetes: randomized clinical trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594399/
https://www.ncbi.nlm.nih.gov/pubmed/37800881
http://dx.doi.org/10.2196/47089
work_keys_str_mv AT lestourgeonlauren evaluationofstudyengagementwithanmhealthinterventionthr1vetotreatdiabetesdistressinteenswithtype1diabetesrandomizedclinicaltrial
AT bergnererin evaluationofstudyengagementwithanmhealthinterventionthr1vetotreatdiabetesdistressinteenswithtype1diabetesrandomizedclinicaltrial
AT datyekarishma evaluationofstudyengagementwithanmhealthinterventionthr1vetotreatdiabetesdistressinteenswithtype1diabetesrandomizedclinicaltrial
AT streisandrandi evaluationofstudyengagementwithanmhealthinterventionthr1vetotreatdiabetesdistressinteenswithtype1diabetesrandomizedclinicaltrial
AT jasersarah evaluationofstudyengagementwithanmhealthinterventionthr1vetotreatdiabetesdistressinteenswithtype1diabetesrandomizedclinicaltrial